Skip to content

Evaluation of the Bone Incremental Effect of Calcium Silicon Bioceramic Bone Restoration Materials for Implant Repair of Multiple Continuous Tooth Defects

Evaluation of the Bone Incremental Effect of Calcium Silicon Bioceramic Bone Restoration Materials for Implant Repair of Multiple Continuous Tooth Defects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097629
Enrollment
Unknown
Registered
2025-02-22
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insufficient bone mass in dental implant alveolar bone

Interventions

Sponsors

West China Hospital of Stomatology Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Age range of 18-70 years old (including upper and lower limits), gender is not limited; 2.Continuous loss of 2-3 tooth positions, and the duration of tooth loss is greater than 3 months; 3.Simple horizontal buccal bone defect, defect type is two wall or three wall bone defect, requiring simultaneous implantation Guided bone regeneration surgery; 4.Periodontal health, adjacent teeth health without restorations; 5.The patient voluntarily participates in the clinical study and signs the 'Informed Consent Form'.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of preservation of alveolar bone sites in the tested tooth position; 2.Malignant tumors, active infectious lesions, and various defects generated during the active phase of metabolic bone diseases; 3.Patients with a history of acute periapical periodontitis, progressive periodontal disease, refractory periodontitis, severe habitual bruxism, infection, etc; 4.Patients with bone metabolism disorders (such as osteoporosis, abnormal osteoarthritis, etc.), or those who have taken drugs or products that can significantly affect bone metabolism (such as steroids, bisphosphonates, etc.) within the past 3 months before enrollment; 5.History of head and neck radiotherapy; 6.Patients who are unable to undergo oral imaging examinations and those who may experience dental imaging artifacts that affect outcome evaluation; 7.Patients who have taken anticoagulant drugs or have abnormal coagulation function in the past 3 months and are deemed unsuitable for surgery by researchers; 8.Patients with abnormal liver and kidney function (ALT and AST values exceeding 1.5 times the upper limit of normal, or creatinine exceeding normal); 9.Poorly controlled diabetes (fasting blood glucose >= 8 mmol/L), poorly controlled hypertension (systolic blood pressure >= 160 mmHg and/or diastolic blood pressure >= 100 mmHg); 10.Pregnant and intending pregnant women of childbearing age and lactating women; 11.Patients who smoke heavily (>= 10 cigarettes/day); 12.Patients with severe mental illness, alcohol or drug abuse; 13.The patient has participated in or is currently participating in clinical trials of other drugs or devices within the past 3 months; 14.Other patients deemed unsuitable for inclusion by researchers.

Design outcomes

Primary

MeasureTime frame
Changes of average thickness of alveolar bone on labial and buccal side of implant;

Secondary

MeasureTime frame
Wound healing of gingival tissue in the implanted area;

Countries

China

Contacts

Public ContactZhang Shiwen

West China Hospital of Stomatology Sichuan University

sw.zhang2018@scu.edu.cn+86 199 4071 2565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026